In this study, we focus on ROR1 with the motivation that cytoskeleton disruption in AD due to Aβ1–42 is a well recognised hallmark5–9 and we could establish the same through biochemical assays and confocal imaging. Here, ROR1 is linked to Alzheimer disease.